What's in Nanjing Sanhome Pharmaceutical, Co., Ltd.'s pipeline?

Nanjing Sanhome Pharmaceutical, Co., Ltd. has 15 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 5 in Phase 2, 8 in Phase 1.

Which companies overlap with Nanjing Sanhome Pharmaceutical, Co., Ltd.'s portfolio?

Top competitors by shared drug class: Abivax S.A., Akorn, Inc., Guangdong Hengrui Pharmaceutical Co., Ltd, Health Research, Inc., Imperial College London.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/nanjing-sanhome-pharmaceutical-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Nanjing Sanhome Pharmaceutical, Co., Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Nanjing Sanhome Pharmaceutical, Co., Ltd. pipeline: 0 marketed, 0 filed, 2 Phase 3, 5 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 5 Phase 2 8 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
SH-1028 tablets	SH-1028 tablets	phase 3	Small molecule	Unknown	Unknown
Placebo Gefitinib	Placebo Gefitinib	phase 3			Oncology

Therapeutic area mix

Oncology · 1
Unknown · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Abivax S.A. · 1 shared drug class
Akorn, Inc. · 1 shared drug class
Guangdong Hengrui Pharmaceutical Co., Ltd · 1 shared drug class
Health Research, Inc. · 1 shared drug class
Imperial College London · 1 shared drug class
Jiangsu HengRui Medicine Co., Ltd. · 1 shared drug class
Pfizer · 1 shared drug class
Second Affiliated Hospital of Wenzhou Medical University · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Nanjing Sanhome Pharmaceutical, Co., Ltd.:

Cite this brief

Drug Landscape (2026). Nanjing Sanhome Pharmaceutical, Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/nanjing-sanhome-pharmaceutical-co-ltd. Accessed 2026-05-17.